EG20569A - Novel (1-heteroazolyl -1- heterocyclyl ) alkane derivatives and their use as neuroprotective agents - Google Patents

Novel (1-heteroazolyl -1- heterocyclyl ) alkane derivatives and their use as neuroprotective agents

Info

Publication number
EG20569A
EG20569A EG40594A EG40594A EG20569A EG 20569 A EG20569 A EG 20569A EG 40594 A EG40594 A EG 40594A EG 40594 A EG40594 A EG 40594A EG 20569 A EG20569 A EG 20569A
Authority
EG
Egypt
Prior art keywords
heteroazolyl
heterocyclyl
novel
neuroprotective agents
alkane derivatives
Prior art date
Application number
EG40594A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of EG20569A publication Critical patent/EG20569A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EG40594A 1993-07-06 1994-07-06 Novel (1-heteroazolyl -1- heterocyclyl ) alkane derivatives and their use as neuroprotective agents EG20569A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302332A SE9302332D0 (sv) 1993-07-06 1993-07-06 New compounds

Publications (1)

Publication Number Publication Date
EG20569A true EG20569A (en) 1999-08-30

Family

ID=20390539

Family Applications (1)

Application Number Title Priority Date Filing Date
EG40594A EG20569A (en) 1993-07-06 1994-07-06 Novel (1-heteroazolyl -1- heterocyclyl ) alkane derivatives and their use as neuroprotective agents

Country Status (24)

Country Link
US (2) US5731335A (xx)
EP (1) EP0707584A1 (xx)
JP (1) JPH08512312A (xx)
CN (1) CN1126994A (xx)
AU (1) AU691506B2 (xx)
BR (1) BR9406923A (xx)
CA (1) CA2164856A1 (xx)
CZ (1) CZ5396A3 (xx)
EE (1) EE03193B1 (xx)
EG (1) EG20569A (xx)
FI (1) FI960076A (xx)
HU (1) HUT75097A (xx)
IL (1) IL110157A (xx)
IS (1) IS4182A (xx)
MX (1) MX9405110A (xx)
NO (1) NO305955B1 (xx)
NZ (1) NZ268689A (xx)
PL (1) PL176471B1 (xx)
RU (1) RU2124011C1 (xx)
SE (1) SE9302332D0 (xx)
SG (1) SG64891A1 (xx)
SK (1) SK159895A3 (xx)
WO (1) WO1995001979A1 (xx)
ZA (1) ZA944569B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
DE19645313A1 (de) 1996-11-04 1998-05-07 Basf Ag Substituierte 3-Benzylpyrazole
WO1999025346A1 (en) * 1997-11-19 1999-05-27 Takeda Chemical Industries, Ltd. Novel apoptosis inhibitors
AR035016A1 (es) 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
AU2001245897B2 (en) * 2000-03-24 2006-07-06 Euro-Celtique S.A. Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
BRPI0506749A (pt) 2004-01-12 2007-05-22 Applied Research Systems derivados de tiazol e uso dos mesmos
BRPI0515108A (pt) * 2004-09-10 2008-07-01 Syngenta Ltd composto, composições para controlar e evitar microorganismos patogênicos vegetais, e para tratar uma infecção fúngica, e, métodos para controlar ou evitar infestação de plantas cultivadas por microorganismos patogêncos, infestação de material de propagação vegetal por microorganismos patogênicos, e infestação de um material técnico por microorganismos patogênicos, para tratar uma infecção fúngica em um paciente em necessidade deste, e para fabricar um composto
US7888376B2 (en) * 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008147786A1 (en) * 2007-05-23 2008-12-04 Allergan, Inc. ((bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
WO2009123164A1 (ja) * 2008-04-02 2009-10-08 塩野義製薬株式会社 血管内皮リパーゼ阻害活性を有するヘテロ環誘導体
WO2012010567A1 (en) * 2010-07-19 2012-01-26 Syngenta Participations Ag Isoxazole, isothiazole, furane and thiophene compounds as microbicides
EP2447261A1 (en) * 2010-10-29 2012-05-02 Basf Se Pyrrole, furane and thiophene derivatives and their use as fungicides
EP2751117A4 (en) * 2011-08-30 2015-06-24 Innocrin Pharmaceuticals Inc METALLOENZYMHEMMERVERBINDUNGEN

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な1,2,4−オキサジアゾ−ル誘導体
JPH01249760A (ja) * 1988-03-29 1989-10-05 Yamaha Corp ホトクロミック化合物
US5068237A (en) * 1990-05-21 1991-11-26 Warner-Lambert Company Substituted furans and derivatives thereof acting at muscarinic receptors
WO1993013083A1 (en) * 1991-12-31 1993-07-08 Fujisawa Pharmaceutical Co., Ltd. Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity

Also Published As

Publication number Publication date
MX9405110A (es) 1995-01-31
IL110157A0 (en) 1994-10-07
WO1995001979A1 (en) 1995-01-19
PL176471B1 (pl) 1999-06-30
HUT75097A (en) 1997-04-28
CZ5396A3 (en) 1996-06-12
NO960028D0 (no) 1996-01-04
SG64891A1 (en) 1999-05-25
BR9406923A (pt) 1996-07-30
HU9503744D0 (en) 1996-02-28
CA2164856A1 (en) 1995-01-19
RU2124011C1 (ru) 1998-12-27
CN1126994A (zh) 1996-07-17
SK159895A3 (en) 1996-09-04
AU691506B2 (en) 1998-05-21
FI960076A0 (fi) 1996-01-08
AU7197794A (en) 1995-02-06
US5731335A (en) 1998-03-24
IS4182A (is) 1995-01-07
US5607956A (en) 1997-03-04
FI960076A (fi) 1996-01-08
EE03193B1 (et) 1999-06-15
NO960028L (no) 1996-02-27
NZ268689A (en) 1997-11-24
PL312417A1 (en) 1996-04-15
ZA944569B (en) 1995-02-15
SE9302332D0 (sv) 1993-07-06
JPH08512312A (ja) 1996-12-24
NO305955B1 (no) 1999-08-23
IL110157A (en) 2000-01-31
EP0707584A1 (en) 1996-04-24

Similar Documents

Publication Publication Date Title
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
AU7207094A (en) Wrist brace
GB9302130D0 (en) Cleasing composition
EG20569A (en) Novel (1-heteroazolyl -1- heterocyclyl ) alkane derivatives and their use as neuroprotective agents
GB9313274D0 (en) Composition
HU9503742D0 (en) Novel (1-phenyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents
HU9503281D0 (en) Thioindole pyperidinyl derivatives used as antalgics
EP0461499A3 (en) Use of efomycins a, e and g as antiinflammatory agents
GB9322576D0 (en) Antihaemostatic agents
ZA947258B (en) Novel triaryl-ethylene derivatives
GB2281914B (en) Composition
HU9400610D0 (en) Iodoaniline derivatives and compositions containing them
HU9603386D0 (en) Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents
GB2282385B (en) Composition
HU9402534D0 (en) New naphtoxazine derivatives
HU9500193D0 (en) Pyridoindolo-benzo-diazepines and derivatives as antipsychotics
GB9306456D0 (en) Composition and use
ZA945327B (en) Azalicyclooctane derivatives as anti-arrhythmic agents
HU9500177D0 (en) 3-aryluracil derivatives and their use as herbicides
GB9408859D0 (en) Composition and use
GB9315200D0 (en) New use and compositions
ZA947921B (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
AU118891S (en) Braces
ZA944932B (en) Use of phenalkylamines
AU119638S (en) Nappy